Network Bio to Build the First Cell-Free RNA Sequence Foundation Model for General Medical Intelligence with NVIDIA
Network Bio, a biotechnology company, today announced a collaboration with NVIDIA to accelerate development of the world's first foundation model trained on cell-free RNA (cfRNA). The collaboration will combine Network Bio's datasets from patient-derived tissues, paired blood samples linked to longitudinal clinical outcomes with NVIDIA’s accelerated computing, NVIDIA Parabricks, and NVIDIA BioNeMo Recipes to advance disease detection, biomarker discovery and drug development.
Network Bio Launches with $50 Million Financing and World’s Largest Patient Tissue Training Dataset
Network Bio, a biotechnology company building disease-specific AI models from human biological data to support the personalized practice of medicine, launched today with $50 million in financing. Investors include Section 32, Thiel Bio, Founders Fund, Breyer Capital, Blue Venture Fund, JSL Health Capital and other life science and AI funds.
